Chandan K Das

olaparib lymphoma cancer maintenance therapy parp chemotherapy metástasis medical oncology platinum refractory ovary cancer bevacizumab relapsed ca ovary pembrolizumab immunotherapy nhl dlbcl follicular lymphoma rituximab neuroendocrine tumor asco ash multiple myeloma auto transplant bladder cancer avelumab ca ub urothelial cancer pancreas hrr germline brca ca pancreas palola1 sol2 solo1 rucaparib niraparib parp inhibitor ovarian cancer gynecological cancer cancer ca ovary 5ht3antagonist nk1 antagonist ondansetron palonosetron apprepitant cisplatin vomiting netupitant nepa cinv vip bep nonseminoma seminoma gct nsgct germcell tumor testicular cancer pgi keynote lupsma ra223 mitoxantrone carboplatin carcinoma relpase docetaxel abiraterone enzalutamide cabazitaxel ca prostate prostate crpc bcnu bloodcsfbarrier bbb oncology pcv hd methotrexate temozolamide brain cancer stupp gbm glioma braintumor cns platinum resistant platinum sensitive refractory how i treat lipodox pld ovary car t cell anti id vaccine biovax hodgkin's lymphoma nivolumab cd38 daratumumab who ibrutinib bendamustine burkitt's ptcl prrt net carcinoid ki 67 gep net brentuximab biliary tract malignancy panitumumab 2014 cytogenetics medulloblastoma bkv transplant hsct